Search Results - Stuart McCracken

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Human PIRH2 Enhances Androgen Receptor Signaling through Inhibition of Histone Deacetylase 1 and Is Overexpressed in Prostate Cancer

    Human PIRH2 Enhances Androgen Receptor Signaling through Inhibition of Histone Deacetylase 1 and Is Overexpressed in Prostate Cancer by Ian R. Logan, Luke Gaughan, Stuart McCracken, Vasileia Sapountzi, Hing Y. Leung, Craig Robson

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities

    A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities by Evangelia E. Kounatidou, Sirintra Nakjang, Stuart McCracken, Scott M. Dehm, Craig Robson, Dominic Jones, Luke Gaughan

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer

    Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer by Bharat Gowardhan, D. A. Douglas, Marie E. Mathers, Arthur B. McKie, Stuart McCracken, Craig Robson, Hing Y. Leung

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study

    Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study by Lois G. Kim, Nicholas Boxall, Anne George, Keith Burling, Pete Acher, Jonathan Aning, Stuart McCracken, Toby Page, Vincent J. Gnanapragasam

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis

    SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis by Meiling Gao, Rachana Patel, Imran Ahmad, Janis Fleming, Joanne Edwards, Stuart McCracken, Kanagasabai Sahadevan, Morag Seywright, Jim C. Norman, Owen J. Sansom, Hing Y. Leung

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Regulation of the androgen receptor by SET9-mediated methylation

    Regulation of the androgen receptor by SET9-mediated methylation by Luke Gaughan, Jacqueline Stockley, Nan Wang, Stuart McCracken, Achim Treumann, Kelly Armstrong, Fadhel S. Shaheen, Kate Watt, Iain J. McEwan, Chenguang Wang, Richard G. Pestell, Craig Robson

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    ERK5 signalling in prostate cancer promotes an invasive phenotype

    ERK5 signalling in prostate cancer promotes an invasive phenotype by Alison Ramsay, Stuart McCracken, Madiha Emran Soofi, Janis Fleming, Agnes Yu, Imran Ahmad, Rosie Morland, Laura M. Machesky, Colin Nixon, Dylan R. Edwards, Robert K. Nuttall, Morag Seywright, Rodolfo Márquez, Evan T. Keller, Hing Y. Leung

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth

    FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth by Greg N. Brooke, Rachel L. Culley, D. Alwyn Dart, David J. Mann, Luke Gaughan, Stuart McCracken, Craig Robson, Bradley Spencer‐Dene, Simon C. Gamble, Sue M. Powell, Robin Wait, Jonathan Waxman, Marjorie M. Walker, Charlotte L. Bevan

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: